Sample result
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
SIINFEKL, an exact peptide
Exact text → Patent proteins
Every list and the search record, one sheet each.
- Query
- SIINFEKL · 8 lettersSIINFEKL
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 771 sequences, 2,028 publications, 1,357 families
Charts
Identity against coverage
771 hits by identity and query coverage. 771 with a date.
Show table
| Band | Has a date | All |
|---|---|---|
| 100% | 771 | 771 |
| Band | Has a date | All |
|---|---|---|
| 100% | 771 | 771 |
Hits by year
1,357 families by year of first publication, 1994 to 2026.
Show table
| Year | Has a date | All |
|---|---|---|
| 1994 | 1 | 1 |
| 1995 | 1 | 1 |
| 1998 | 5 | 5 |
| 1999 | 4 | 4 |
| 2000 | 2 | 2 |
| 2001 | 23 | 23 |
| 2002 | 14 | 14 |
| 2003 | 17 | 17 |
| 2004 | 15 | 15 |
| 2005 | 37 | 37 |
| 2006 | 31 | 31 |
| 2007 | 29 | 29 |
| 2008 | 28 | 28 |
| 2009 | 32 | 32 |
| 2010 | 32 | 32 |
| 2011 | 48 | 48 |
| 2012 | 35 | 35 |
| 2013 | 46 | 46 |
| 2014 | 42 | 42 |
| 2015 | 61 | 61 |
| 2016 | 69 | 69 |
| 2017 | 79 | 79 |
| 2018 | 82 | 82 |
| 2019 | 86 | 86 |
| 2020 | 80 | 80 |
| 2021 | 87 | 87 |
| 2022 | 66 | 66 |
| 2023 | 94 | 94 |
| 2024 | 102 | 102 |
| 2025 | 81 | 81 |
| 2026 | 28 | 28 |
Where hits align on the query
The top 20 hits on SIINFEKL, a query of 8 amino acids: 20 cover the whole query, none differs from it.
Show table
| Hit | Query from | Query to | Identity | Differs at | Gaps at | X at |
|---|---|---|---|---|---|---|
| AAE13361.1 | 1 | 8 | 100.0% | None | None | None |
| AAA94863.1 | 1 | 8 | 100.0% | None | None | None |
| AAC86077.1 | 1 | 8 | 100.0% | None | None | None |
| AAO94511.1 | 1 | 8 | 100.0% | None | None | None |
| AAO94501.1 | 1 | 8 | 100.0% | None | None | None |
| CS072231.1 | 1 | 8 | 100.0% | None | None | None |
| CS072222.1 | 1 | 8 | 100.0% | None | None | None |
| AZK27020.1 | 1 | 8 | 100.0% | None | None | None |
| CS072221.1 | 1 | 8 | 100.0% | None | None | None |
| ABH87918.1 | 1 | 8 | 100.0% | None | None | None |
| ABH87917.1 | 1 | 8 | 100.0% | None | None | None |
| ABH87919.1 | 1 | 8 | 100.0% | None | None | None |
| AX288232.1 | 1 | 8 | 100.0% | None | None | None |
| AX288234.1 | 1 | 8 | 100.0% | None | None | None |
| AX288233.1 | 1 | 8 | 100.0% | None | None | None |
| AX288231.1 | 1 | 8 | 100.0% | None | None | None |
| AX288237.1 | 1 | 8 | 100.0% | None | None | None |
| AX288235.1 | 1 | 8 | 100.0% | None | None | None |
| AX288236.1 | 1 | 8 | 100.0% | None | None | None |
| AQN09305.1 | 1 | 8 | 100.0% | None | None | None |
Patents 2K
2,028 publications in 1,357 families match these filters.
-
EP 1981534-A22008-10-22
Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
MED COLLEGE GEORGIA RES INST
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
JP 2008543301-A2008-12-04
AGENTS AND METHODS BASED ON THE USE OF EDA DOMAIN OF FIBRONECTIN
PROYECTO DE BIOMEDICINA CIMA S L
Best alignment
Query 1 to 8, hit 95 to 102. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 95 SIINFEKL 1028 of 8 identical, no gaps.
-
EP 1998801-A22008-12-10
Tem8 as an adjuvant and uses thereof
SLOAN KETTERING INST CANCER
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
JP 2008544760-A2008-12-11
Obtention of food- or auto-antigen specific Tr1 cells from a leukocyte or PBMC population
Institut National de la Sante et de la Recherche Medicale
Family of 2
Best alignment and family
Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 258 SIINFEKL 2658 of 8 identical, no gaps.
Family of 2
Grouped by a shared priority claim, EP 05291429.8.
- JP 2008544760-A2008-12-11
- JP 2013240334-A2013-12-05
-
JP 2008545180-A2008-12-11
System and Method for Automated Selection of T-Cell Epitopes
Merck and Co Inc
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2008545180-A2008-12-11
- US 7756644-B22010-07-13
-
JP 2008308474-A2008-12-25
Preparating method for antigenic oligopeptide
NITTO DENKO CORPORATION
Best alignment
Query 1 to 8, hit 2 to 9. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 2 SIINFEKL 98 of 8 identical, no gaps.
-
JP 2008546775-A2008-12-25
MODULATION OF NEGATIVE IMMUNE REGULATORS AND APPLICATIONS FOR IMMUNOTHERAPY
Baylor College of Medicine
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2008546775-A2008-12-25
- US 7868159-B22011-01-11
-
WO 2009013484-A12009-01-29
Immune modulation via c-type lectin
Sancho-Madrid, David (GB)
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 2024538-A22009-02-18
Compositions for and methods of identifying antigens
HARVARD COLLEGE
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2024538-A22009-02-18
- EP 2537932-A12012-12-26
-
US 7498046-A2009-03-03
Composition for inducing immune response comprising inverted microsomes
Queen Mary & Westfield College
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7501119-A2009-03-10
Methods and molecules for modulating an immune response
Mayo Foundation for Medical Education and Research
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7501125-A2009-03-10
Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
JP 2009079048-A2009-04-16
Modified Peptides YY and Conjugates Thereof
ConjuChem Biotechnologies Inc
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2009079048-A2009-04-16
- JP 2010168384-A2010-08-05
-
WO 2009060086-A22009-05-14
Increase of immune response and targeting by antigens and/or drug linkage
Wittycell (FR)
Best alignment
Query 1 to 8, hit 9 to 16. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 9 SIINFEKL 168 of 8 identical, no gaps.
-
KR 1020090051598-A2009-05-22
Vaccine comprising Monocyte or immature myeloid cells(IMC) which was loaded with the ligand of natural killer T cell and antigen
Seoul National University Industry Foundation
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020090051598-A2009-05-22
- KR 1020100114873-A2010-10-26
-
US 7538083-A2009-05-26
Compositions and methods for the potentiation of immune responses against target antigens
Intercell AG
Best alignment
Query 1 to 8, hit 12 to 19. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 12 SIINFEKL 198 of 8 identical, no gaps.
-
EP 2062592-A12009-05-27
System for delivery into a XCR1 positive cell and uses thereof
BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Prasidenten (DE)
Family of 3
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 3
Grouped by a shared priority claim, EP 07022471.2.
- EP 2062592-A12009-05-27
- JP 2011503219-A2011-01-27
- JP 2015007052-A2015-01-15
-
JP 2009520772-A2009-05-28
NOVEL T-HELPER ANTIGENIC DETERMINANT (THD) PEPTIDES
PROYECTO DE BIOMEDICINA CIMA S L
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2009065561-A22009-05-28
System for delivery into a xcr1 positive cell and uses thereof
Bundesrepublik Deutschland Letztvertreten Durch Das Robert Koch- Institut (DE)
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2009065982-A12009-05-28
Peptides that can bind to scurfin and uses thereof
Proyecto de Biomedicina Cima, S.L. (ES)
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2009071852-A22009-06-11
Functionalised biochips for spr-ms coupling
Centre National de la Recherche Scientifique (FR)
Best alignment
Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 258 SIINFEKL 2658 of 8 identical, no gaps.
-
EP 2069381-A22009-06-17
Agents and methods to elicit anti-tumor immune response
UNIV COLUMBIA
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2009077436-A22009-06-25
Method for preparing protein conjugates
GlaxoSmithKline Biologicals S.A. (BE)
Family of 2
Best alignment and family
Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 258 SIINFEKL 2658 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2009077436-A22009-06-25
- WO 2009077438-A12009-06-25
-
EP 2076272-A22009-07-08
Generating an immune response by inducing cd40 and pattern recognition receptors
BAYLOR COLLEGE MEDICINE
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2009088401-A22009-07-16
Immunostimulatory combinations of tlr ligands and methods of use
Department of Health and Human Services (US)
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7563882-A2009-07-21
Polynucleotides encoding antibodies that bind to the C35 polypeptide
University of Rochester
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 7563882-A2009-07-21
- US 7879990-B22011-02-01
-
JP 2009528065-A2009-08-06
ENGINEERED LISTERIA AND METHODS OF USE THEREOF
Anza Therapeutics Inc
Best alignment
Query 1 to 8, hit 142 to 149. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 142 SIINFEKL 1498 of 8 identical, no gaps.
-
EP 2097927-A12009-09-09
Systems and methods for cmos-compatible silicon nano-wire sensors with biochemical and cellular interfaces
UNIV YALE
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7589174-A2009-09-15
GRP94-based compositions and methods of use thereof
The Children's Hospital of Philadelphia and The University of Chicago
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 2100901-A12009-09-16
Modified Insulin and conjugates thereof
ConjuChem Biotechnologies Inc. (CA)
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7595060-A2009-09-29
Yeast-antigen compositions methods of making the same
GlobeImmune, Inc. and The Regents of the University of Colorado
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
JP 2009535059-A2009-10-01
CD40 AGONIST ANTIBODY/TYPE 1 INTERFERON SYNERGISTIC ADJUVANT COMBINATION, CONJUGATES CONTAINING AND USE THEREOF AS A THERAPEUTIC TO ENHANCE CELLULAR IMMUNITY
ROSS KEDL,PHILLIP J SANCHEZ,CATHERINE HALUSZCZAK
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 60/796867.
- JP 2009535059-A2009-10-01
- JP 2014027935-A2014-02-13
-
KR 1020090109122-A2009-10-19
THERAPEUTIC AGENT FOR CANCER
THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020090109122-A2009-10-19
- KR 1020120098919-A2012-09-05
-
EP 2114416-A12009-11-11
Method of inducing an immune response
UNIV QUEENSLAND
Family of 2
Best alignment and family
Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 258 SIINFEKL 2658 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2114416-A12009-11-11
- EP 3042959-A12016-07-13
-
US 7622273-A2009-11-24
Method for chemical and enzymatic treatment of posttranslationally modified proteins bound to a protein chip
Best alignment
Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 257 SIINFEKL 2648 of 8 identical, no gaps.
-
JP 2009273377-A2009-11-26
Method for selecting candidate peptides which bind to MHC class I molecules and express on the cancer cell surface
MEDICAL AND BIOLOGICAL LABORATORIES CO LTD,KEIO UNIVERSITY
Best alignment
Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 6 SIINFEKL 138 of 8 identical, no gaps.
-
US 7625567-A2009-12-01
Induction of immune responses to isoaspartyl-modified antigens
Yale University
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7632514-B22009-12-15
Universal carrier for targeting molecules to Gb3 receptor expressing cells
Institute Curie, Centre National de la Recherche Scientifque, Institut National de la Sante et de la Recherche Medicale and Universite Pierre et Marie Curie (Paris VI)
Best alignment
Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 6 SIINFEKL 138 of 8 identical, no gaps.
-
JP 2009544291-A2009-12-17
A CANCER VACCINE COMPRISING A MUCIN 1 (MUC1) T CELL EPITOPE-DERIVED PEPTIDE
4G VACCINES PTY LTD
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 2139913-A22010-01-06
Inducing immune-mediated tumor cell death
MAYO FOUNDATION
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7691393-B22010-04-06
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
Anza Therapeutics, Inc.
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 7695725-B22010-04-13
Modified free-living microbes, vaccine compositions and methods of use thereof
Aduro Biotech
Family of 3
Best alignment and family
Query 1 to 8, hit 192 to 199. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 192 SIINFEKL 1998 of 8 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 7695725-B22010-04-13
- US 7833775-B22010-11-16
- US 7927606-B22011-04-19
-
WO 2010040847-A12010-04-15
Recombinant protein bodies as immunogen-specific adjuvants
ERA Biotech, S.A. (ES)
Family of 3
Best alignment and family
Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 258 SIINFEKL 2658 of 8 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2010040847-A12010-04-15
- KR 1020110084906-A2011-07-26
- US 9555097-B22017-01-31
-
US 7705199-B22010-04-27
Compositions and methods for treatment of autoimmune and related diseases
The Scripps Research Institute
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 2178548-A12010-04-28
Survivin peptides as cancer vaccines
HEALTH RESEARCH INC
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2178548-A12010-04-28
- US 7943138-B22011-05-17
-
WO 2010050190-A2010-05-06
Molecular markers for cancer stem cells
Japan Science and Technology Agency,Sapporo Medical University
Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2010050190-A2010-05-06
- WO 2010107116-A2010-09-23
-
EP 2185577-A22010-05-19
Chlamydia antigens
HARVARD COLLEGE
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2010055340-A12010-05-20
Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
LUDWIG INSTITUTE FOR CANCER RESEARCH (US)
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2010061930-A2010-06-03
Immunotherapy by using allogenic cell capable of co-expressing target antigen and CD1d
RIKEN
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2010063865-A12010-06-10
Use of phenol-soluble modulins for vaccine development
Institut Pasteur (FR)
Best alignment
Query 1 to 8, hit 23 to 30. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 23 SIINFEKL 308 of 8 identical, no gaps.